MDT Q2 2019 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$114B

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7.5B+6.1% YoY

Gross Profit

$5.3B70.6% margin

Operating Income

$1.5B20.6% margin

Net Income

$1.1B14.9% margin

EPS (Diluted)

$0.82

QoQ Revenue Growth

+1.3%

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$957M

Stock-Based Comp.

$104M

Balance Sheet

Total Assets

$88.2B

Total Liabilities

$38.4B

Stockholders' Equity

$49.6B

Cash & Equivalents

$3.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.5B	$7.0B	+6.1%
Gross Profit	$5.3B	$4.9B	+7.1%
Operating Income	$1.5B	$1.9B	-18.5%
Net Income	$1.1B	$2.0B	-44.7%

Revenue Segments

Cardiac and Vascular Group

$2.9B38%

Minimally Invasive Therapies Group

$2.0B27%

Restorative Therapies Group

$2.0B27%

Diabetes Group

$583M8%

Geographic Segments

UNITED STATES

$4.0B54%

Total Other Countries, Excluding United States and Ireland

$3.4B46%

IRELAND

$22M0%